WAVE Life Sciences (WVE) no longer intends to offers ordinary shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Form 424B5 Wave Life Sciences Ltd.
September 24, 2024 5:16 PM EDTTable of Contents
Filed Pursuant to Rule 424(b)(5)
Registration No. 333-263251
The information in this preliminary prospectus supplement is not complete and may be changed. A registration statement relating to these securities has been declared effective by the Securities and Exchange... More
Form 424B3 Wave Life Sciences Ltd.
September 24, 2024 5:14 PM EDTFiled Pursuant to Rule 424(b)(3)
Registration No. 333-263251
... More



